Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: For TTCCRR

Re: Question about ownership ....

posted on Jun 13, 2007 11:22AM
Thanks for info/insights, gabby. I like buyback idea too. I think it's possible that PTSC could own more than 14 million additional, a lot more, since revenue accumulation / share buybacks are in real time, and all reporting is historical. PR seems intenionally muted and reporting for all companies trails actual events by at least a month, usually more. Don't know of any way to get more immediate data w/o being on the BOD or Turley's assistant! Will be interesting to see if PTSC is shrinking the float slowly or not so slowly. This seems a very precarious time for Boards to be monkeying around slowly ... IF there is great long-term value. Unprecedented liquidity around the world, unprecedented shrinkage of shares, entire industries being consolidated. Much liquidity in hands of those who can afford to pitch REAL money down on the turn of a card, and put real pressure on companies to perform ... should some of that money become convinced PTSC's interest in the patents has huge upside potential, we will see a quickening of decisions IMHO.
Share
New Message
Please login to post a reply